Abstract:The concept of new and emerging diseases has captured the public interest and has revitalized the public health infectious disease research community. This interest has also resulted in competition for funding and turf wars between animal health and public health scientists and public officials and, in some cases, has delayed and hindered progress toward effective prevention, control and biodefense. There is a dynamic list of outbreaks causing substantial morbidity and mortality in humans and often in the reservoir animal species. Some agents have the potential to grow into major epidemics. There are many determinants that influence the emergence of diseases of concern that require the use of current understanding of the nature of agent persistence and spread. Additional factors that are global must be added to plans for prevention and control. To this complex mix has been added the potential for accidental or malicious release of agents. The nature of emerging infectious agents and their impact is largely unpredictable. Models that strive to predict the dynamics of agents may be useful but can also blind us to increasing disease risks if it does not match a specific model. Field investigations of early events will be critical and should drive prevention and control actions. Many disease agents have developed strategies to overcome extremes of reservoir qualities like population size and density. Every infectious agent spreads easier when its hosts are closer together. Zoonoses must be dealt with at the interface of human and animal health by all available information. Lessons learned from the emergence of and response to agents like West Nile virus, H5N1 avian influenza, SARS and bovine spongiform encephalopathy, the cause of new-variant Creutzfeldt-Jakob disease in humans, must be used to create better plans for response and meet the challenge for public health and biodefense.

Open Source Clinical Science for Emerging Infections

Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections

Integrating biodiversity infrastructure into pathogen discovery and mitigation of emerging infectious diseases

Emerging infections—an increasingly important topic: review by the Emerging Infections Task Force

Combat With Emerging Infectious Diseases: Clinicians Should Do Better

SARS: a case study in emerging infections.

Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision

We need a global framework for promoting safe handling of high consequence pathogens

Pathogens: a new open access journal serving all those interested in infectious disease

Global Outbreak Research: Harmony Not Hegemony

One world, one health: combating infectious diseases in the age of globalization

Rise of the microbes

Avian Influenza: Lessons from Past Outbreaks and an Inventory of Data Sources, Mathematical and AI Models, and Early Warning Systems for Forecasting and Hotspot Detection to Tackle Ongoing Outbreaks

Epidemiology, biosafety, and biosecurity of Avian Influenza: Insights from the East Mediterranean region

Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases

Social and environmental risk factors in the emergence of infectious diseases

Emerging zoonoses: the challenge for public health and biodefense

Joint China-US Call for Employing a Transdisciplinary Approach to Emerging Infectious Diseases

Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases

Eskape Infection Control: Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections (Adv. Sci. 1/2020)

Molecular Pathogenesis of Severe Acute Respiratory Syndrome